EKSO shareholders approve equity plan share increase and all proposals at annual meeting

EKSO BIONICS HOLDINGS, INC.

Elected six directors; average votes for ~4.2M per nominee, with 2.57M broker non-votes each.
Approved equity plan amendment raising authorized shares from 1,974,286 to 2,524,286; 3.9M for, 621k against.
Non-binding say-on-pay approved with 4.24M for, 255k against, 43.6k abstain.
Ratified WithumSmith+Brown as auditor for FY2022 with 6.99M for, 55.7k against.
Approximately 7.1M shares voted of 12.8M outstanding, constituting a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.